Clinical Trials Browser

Phase 1 × Carcinoma, Hepatocellular × LY-2157299 × Clear all

NCT02240433 2020-02-05

A Study of LY2157299 in Participants With Unresectable Hepatocellular Cancer (HCC)

Phase 1 Completed

Gastrointestinal

Carcinoma, Hepatocellular